Saturday, May 18, 2013

Large Compounders’ Reporting Requirements Would Move Closer To Manufacturers’ In Senate Bill

By Derrick Gingery / Email the Author / May 16, 2013 

Executive Summary

Compounding manufacturers would have to report adverse events and quality problems much like traditional drug and biologic makers as a Senate committee moves toward mark up of legislation.
to purchase to read click here

No comments: